Stockscreener 앱 받기
3.07
3.72%
0.11
시간 외 거래:
3.08
0.01
+0.33%
전일 마감가:
$2.96
열려 있는:
$2.94
하루 거래량:
132.09K
Relative Volume:
0.76
시가총액:
$122.19M
수익:
$2.70M
순이익/손실:
$5.53M
주가수익비율:
27.91
EPS:
0.11
순현금흐름:
$-10.55M
1주 성능:
+9.25%
1개월 성능:
+14.13%
6개월 성능:
+40.83%
1년 성능:
+25.31%
1일 변동 폭
$2.91
$3.09
1주일 범위
$2.7508
$3.09
52주 변동 폭
$1.82
$3.24
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
명칭
Oramed Pharmaceuticals Inc
전화
646-844-1164
주소
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
ORMP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
3.07 | 117.82M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-01-12 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-04-20 | 개시 | Canaccord Genuity | Buy |
| 2021-02-09 | 개시 | National Securities | Buy |
| 2020-12-03 | 개시 | Alliance Global Partners | Buy |
| 2020-03-11 | 개시 | Aegis Capital | Buy |
| 2019-09-11 | 개시 | Ladenburg Thalmann | Buy |
| 2017-12-11 | 재개 | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | 재확인 | FBR Capital | Outperform |
| 2015-12-01 | 재확인 | H.C. Wainwright | Buy |
| 2015-11-19 | 개시 | FBR Capital | Outperform |
| 2015-04-13 | 재개 | MLV & Co | Buy |
| 2014-01-30 | 재확인 | Aegis Capital | Buy |
| 2014-01-08 | 재확인 | Aegis Capital | Buy |
| 2014-01-08 | 개시 | MLV & Co | Buy |
| 2013-12-03 | 개시 | Aegis Capital | Buy |
모두보기
Oramed Pharmaceuticals Inc 주식(ORMP)의 최신 뉴스
Oramed Pharmaceuticals director Leonard Sank to resign after 18 years By Investing.com - Investing.com Nigeria
Oramed Pharmaceuticals director Leonard Sank to resign after 18 years - Investing.com
Oramed Pharm Announces Long-Tenured Director’s Upcoming Resignation - TipRanks
Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex - Investing.com Nigeria
Oramed Pharm Completes Warrant Sale, Boosting Liquidity - TipRanks
Oramed Pharmaceuticals Completes Warrant Repurchase with Scilex - TradingView — Track All Markets
Scilex Holding completes $27 million repurchase of warrants from Oramed By Investing.com - Investing.com Nigeria
Scilex Holding completes $27 million repurchase of warrants from Oramed - Investing.com India
Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback - Seeking Alpha
Analyst Downgrade: Will Oramed Pharmaceuticals Inc stock outperform value stocksRate Hike & Daily Market Momentum Tracking - moha.gov.vn
Total debt per share of Oramed Pharmaceuticals Incorporated – TRADEGATE:OJU1 - TradingView — Track All Markets
Is Oramed Pharmaceuticals Inc. (OJU1) stock suitable for passive index fundsQuarterly Profit Review & Reliable Volume Spike Alerts - Улправда
Aug Swings: Will Oramed Pharmaceuticals Inc stock outperform value stocksWeekly Stock Analysis & Expert Verified Stock Movement Alerts - moha.gov.vn
Why Oramed Pharmaceuticals Inc. stock could outperform in 2025Recession Risk & Daily Technical Forecast Reports - Улправда
Oramed Pharmaceuticals (FRA:OJU1) EV-to-OCF : 1.41 (As of Dec. 19, 2025) - GuruFocus
Will Oramed Pharmaceuticals Inc. stock maintain growth storyQuarterly Trade Review & Target Return Focused Picks - DonanımHaber
Can Oramed Pharmaceuticals Inc. stock withstand economic slowdownProduct Launch & Daily Stock Trend Watchlist - DonanımHaber
Will Oramed Pharmaceuticals Inc. stock outperform value stocks2025 Historical Comparison & Fast Exit/Entry Strategy Plans - DonanımHaber
Can Oramed Pharmaceuticals Inc. (OJU1) stock double in coming yearsQuarterly Portfolio Summary & Verified High Yield Trade Plans - DonanımHaber
Oramed Pharmaceuticals And 2 Other Promising Penny Stocks To Watch - Yahoo Finance
MSN Money - MSN
Oramed Pharmaceuticals Earnings Notes - Trefis
How strong dollar benefits Oramed Pharmaceuticals Inc. (OJU1) stockJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - Newser
Why Oramed Pharmaceuticals Inc. stock appeals to analystsJobs Report & Free AI Powered Buy and Sell Recommendations - Newser
Will Oramed Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - Newser
Will Oramed Pharmaceuticals Inc. (OJU1) stock maintain strong growthRate Hike & Community Verified Trade Signals - Newser
How Oramed Pharmaceuticals Inc. (OJU1) stock correlates with oil markets2025 Short Interest & Stock Market Timing Techniques - Newser
How Oramed Pharmaceuticals Inc. (OJU1) stock valuation compares with sectorJuly 2025 Final Week & Weekly Setup with High ROI Potential - Newser
Is Oramed Pharmaceuticals Inc. (OJU1) stock a buy on weakness2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
Is Oramed Pharmaceuticals Inc a good long term investmentSector Performance Review & High Yield Trading Growth - earlytimes.in
ORMP: Advancing Clinical Activities, Generating Gains From Investment Portfolio, New Rights Plan Adopted - Yahoo Finance
Oramed Pharm Repurchases Shares, Ends Joint Venture - MSN
There Are Some Holes In Oramed Pharmaceuticals' (NASDAQ:ORMP) Solid Earnings Release - Yahoo Finance
Oramed Pharmaceuticals' (NASDAQ:ORMP) Profits May Be Overstating Its True Earnings Potential - simplywall.st
Why Oramed Pharmaceuticals Inc. (OJU1) stock attracts HNW investorsTrade Analysis Report & Expert Approved Momentum Ideas - newser.com
What market sentiment indicators show for Oramed Pharmaceuticals Inc. (OJU1) stockMarket Rally & High Accuracy Trade Signal Alerts - newser.com
Is Oramed Pharmaceuticals Inc. stock overvalued by current metricsBull Run & Consistent Return Strategy Ideas - newser.com
Head-To-Head Comparison: Oramed Pharmaceuticals (NASDAQ:ORMP) and Zimmer Biomet (NYSE:ZBH) - Defense World
How Oramed Pharmaceuticals Inc. (OJU1) stock performs during market turbulence2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock vulnerable to rate hikes2025 Top Decliners & AI Driven Price Predictions - newser.com
Is Oramed Pharmaceuticals Inc. (OJU1) stock a fit for income portfoliosQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com
Is Oramed Pharmaceuticals Inc. stock a top pick in earnings seasonQuarterly Market Summary & Stepwise Swing Trade Plans - newser.com
Oramed Pharmaceuticals Inc (ORMP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):